- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05676762
Contraceptive Counselling: Impact on Awareness of the Risk of Unwanted Pregnancy and on the Appeal of Contraception (CMC)
January 6, 2023 updated by: Centre Hospitalier Universitaire de la Réunion
Le Conseil Minimal Autour de la Contraception : Quel Impact Sur la Prise de Conscience du Risque de Grossesse Non désirée et Sur l'Attrait à la Contraception
The hypothesis of this study is that the generalisation of minimal contraceptive advice in general medical consultations among women of childbearing age in Reunion Island who do not use contraception but who have sexual relations and do not wish to become pregnant within the year could induce an awareness of the risk of unwanted pregnancy and lead to a change in behaviour with regard to contraceptive methods.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Actual)
117
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-Philippe, Réunion, 97442
- Cabinet de médecine générale
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
On the basis of 30 participating GPs, the estimation of the number of inclusions is 400 women, which seems sufficient for this study.
The desired number of inclusions is 45 women/month (400 women over 9 months).
Description
Inclusion Criteria:
- Women from 18 to 50 years old
- Consulting in a general practice in Reunion Island
- French or Creole speaking
- Not having any contraceptive means
- Having sexual intercourse
- Not having any desire to become pregnant within the year
- Collection of non-opposition
Exclusion Criteria:
- Consultation for a desire or follow-up of a pregnancy
- Consultation for an abortion
- Consultation for a contraceptive method
- Known infertility
- Inability to answer the telephone (hearing impaired, mute)
- Severe cognitive disorder (mental retardation, dementia, active psychosis)
- Women under guardianship or curatorship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of a minimal councelling regarding the contraception awareness of risk of unwanted pregnancy
Time Frame: between Day 1 and Month 1
|
Change of Proportion of women with no contraception and having sexual relations without a desire of pregnancy
|
between Day 1 and Month 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sébastien LERUSTE, MD, Universite de La Reunion
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2022
Primary Completion (Actual)
December 15, 2022
Study Completion (Anticipated)
January 15, 2023
Study Registration Dates
First Submitted
July 21, 2022
First Submitted That Met QC Criteria
January 6, 2023
First Posted (Estimate)
January 9, 2023
Study Record Updates
Last Update Posted (Estimate)
January 9, 2023
Last Update Submitted That Met QC Criteria
January 6, 2023
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2021/CHU/34
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States